0000950170-23-033494.txt : 20230719
0000950170-23-033494.hdr.sgml : 20230719
20230719151458
ACCESSION NUMBER: 0000950170-23-033494
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 231096549
BUSINESS ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIOTECH TARGET N V
CENTRAL INDEX KEY: 0001259870
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 231096550
MAIL ADDRESS:
STREET 1: ARA HILL TOP BUILDING, UNIT A-5
STREET 2: PLETTERIJWEG OOST 1, CURACAO
CITY: WILLEMSTAD
STATE: P8
ZIP: 000000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecular Templates, Inc.
CENTRAL INDEX KEY: 0001183765
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943409596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
BUSINESS PHONE: 512 896 1555
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
FORMER COMPANY:
FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020828
4
1
ownership.xml
4
X0508
4
2023-07-17
0001183765
Molecular Templates, Inc.
MTEM
0001259870
BIOTECH TARGET N V
ARA HILL TOP BUILDING, UNIT A-5
PLETTERIJWEG OOST 1
CURACAO
P8
00000
NETHERLANDS ANTILLES
false
false
true
false
0000924223
BB BIOTECH AG
SCHWERTSTRASSE 6
SCHAFFHAUSEN
V8
CH-8200
SWITZERLAND
false
false
true
false
false
Common Stock
2023-07-17
4
P
false
4255319
0.470
A
15447322
D
Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.
/s/Ivo Betschart
2023-07-19
/s/Martin Gubler
2023-07-19